Course Overview
By the 300 level you already know the pieces. You can read a lipid panel against its reference interval (TWI 202), follow a GLP-1 titration schedule (TWI 205), load a tendon (TWI 210), interpret a DXA scan against its least significant change (TWI 208), and price a membership that holds its margin (TWI 102). What no single course could teach is what happens when those pieces meet one patient: the medication plan outruns the strength plan, the budget cuts the ideal sequence in half, the physician partner wants to inject before the loading trial is finished, or the right answer is to stop and refer. TWI 301 teaches that judgment through four composite case series and two framework modules, each case worked through the same twelve fields you will use on your own patients, from red-flag screening and RED/YELLOW/GREEN tiering to physician-owned data, a phased plan, the business layer, and outcomes judged against published minimal clinically important differences. The cases: a perimenopausal patient losing lean mass on a GLP-1 agonist; a masters athlete on physician-managed testosterone therapy with recurrent hamstring strains; a chronic Achilles tendinopathy that stalls after shockwave and moves to an orthobiologic referral; and a longevity-focused executive whose lab results point to a referral, not a protocol. One case fails and is modified, one ends in referral, and one is reshaped by cost and patient preference. You leave with six editable tools: a 12-field case workbook, a care-plan sequencer, SBAR and physician-update templates, a tier and referral decision sheet, a case-pricing and margin calculator, and a caseload outcome dashboard that flags MCID and LSC changes automatically.